Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 109Neoplasms 99Lung Neoplasms 60Colorectal Neoplasms 45Prostatic Neoplasms 40Carcinoma, Non-Small-Cell Lung 39Pancreatic Neoplasms 33Melanoma 31Head and Neck Neoplasms 27Neoplastic Cells, Circulating 25Ovarian Neoplasms 24Uterine Cervical Neoplasms 20Sarcoma 19Multiple Myeloma 19Glioma 19Colonic Neoplasms 19Carcinoma, Hepatocellular 17Leukemia, Myeloid, Acute 16Neoplasm Metastasis 15Squamous Cell Carcinoma of Head and Neck 14Lymphoma 14Glioblastoma 14Esophageal Neoplasms 14Endometrial Neoplasms 14Leukemia 12Kidney Neoplasms 11Hematologic Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11Myelodysplastic Syndromes 10

Interventions

fludarabine 2Fingolimod Hydrochloride 2Cyclophosphamide 2Blood Specimen Collection 2teriflunomide 1gadobutrol 1gadobenic acid 1Surveys and Questionnaires 1Specimen Handling 1Respiratory Therapy 1Registries 1Platelet Transfusion 1Phlebotomy 1OM 89 1Nivolumab 1Natalizumab 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Interferon beta-1a 1Gadolinium DTPA 1Fish Oils 1Exergaming 1Dimethyl Fumarate 1Dietary Fiber 1Data Collection 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Multiple Sclerosis × Blood Specimen Collection × Clear all
NCT00704626 2026-05-18

SAA

University of California, Davis

Enrolling by invitation
120 enrolled

Autoimmune Diseases, Multiple Sclerosis, Myasthenia Gravis, Myelitis, Transverse

NCT04844489 2023-02-06

COVIVAC-ID

Assistance Publique - Hôpitaux de Paris

Phase NA Completed
377 enrolled

COVID-19, Multiple Sclerosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡